Hyperglycemia-induced cardiac fibrosis provokes pathological changes that culminate in activation of TGF-β pathway and deposition of ECM proteins leading to increased myocardial stiffness and impaired cardiac function [62]. Here, TGFB1 is linked to Hyperglycemia.